Rev Med Inst Mex Seguro Soc
January 2024
Rev Med Inst Mex Seguro Soc
September 2023
Background: Acute myeloid leukemia (AML) is characterized by the presence of ≥ 20% myeloblasts in peripheral blood or bone marrow, as well as specific cytogenetic alterations. It can appear as a de novo disease or be associated with other hematologic diseases, which is why the clinical presentation is heterogeneous. Pancytopenia as a manifestation of aleukemic leukemia is a rare entity.
View Article and Find Full Text PDF